Lumateperone Found to Be Effective in Treating Bipolar Depression

Patients with bipolar disorder who are experiencing a major depressive episode may benefit from taking the antipsychotic lumateperone, suggests a study in AJP in Advance. The phase 3 trial, which was funded by Intra-Cellular Therapies (maker of lumateperone), revealed that adults taking lumateperone daily reported significantly greater improvements in their depressive symptoms and overall functioning after six weeks than those taking placebo. Lumateperone was also well tolerated, and participants experienced[…]